propofol has been researched along with Adrenal Cortex Diseases in 1 studies
Propofol: An intravenous anesthetic agent which has the advantage of a very rapid onset after infusion or bolus injection plus a very short recovery period of a couple of minutes. (From Smith and Reynard, Textbook of Pharmacology, 1992, 1st ed, p206). Propofol has been used as ANTICONVULSANTS and ANTIEMETICS.
propofol : A phenol resulting from the formal substitution of the hydrogen at the 2 position of 1,3-diisopropylbenzene by a hydroxy group.
Adrenal Cortex Diseases: Pathological processes of the ADRENAL CORTEX.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cotten, JF | 1 |
| Husain, SS | 1 |
| Forman, SA | 1 |
| Miller, KW | 1 |
| Kelly, EW | 1 |
| Nguyen, HH | 1 |
| Raines, DE | 1 |
1 other study available for propofol and Adrenal Cortex Diseases
| Article | Year |
|---|---|
Methoxycarbonyl-etomidate: a novel rapidly metabolized and ultra-short-acting etomidate analogue that does not produce prolonged adrenocortical suppression.
Topics: Adrenal Cortex Diseases; Adrenal Cortex Hormones; Anesthetics, Intravenous; Animals; Biotransformati | 2009 |